Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Case report

Expanded dengue syndrome: subacute thyroiditis and intracerebral hemorrhage

Authors: Muhammad Zaman Khan Assir, Ali Jawa, Hafiz Ijaz Ahmed

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Although most symptomatic dengue infections follow an uncomplicated course, complications and unusual manifestations are increasingly being reported due to rising disease burden. Expanded dengue syndrome is a new entity added into World Health Organization (WHO) classification system to incorporate this wide spectrum of unusual manifestations. We report a case of expanded dengue syndrome with subacute thyroiditis and intracerebral hemorrhage. This is the first case report of thyroiditis in dengue infection.

Case presentation

A 20 years old man presented with fever, myalgias, arthralgias, retro-orbital pain, vomiting and gum bleeding during a large dengue outbreak in Lahore, Pakistan. On 7th day of illness patient became afebrile, but he developed severe headaches, unconsciousness followed by altered behavior. On 9th day of illness patient developed painful neck swelling accompanied by fever, tremors, palpitations, hoarseness of voice and odynophagia. Examination revealed acutely swollen, tender thyroid gland along with features of hyperthyroidism. Laboratory evaluation revealed stable hematocrit, thrombocytopenia and leukopenia. Patient had seroconverted for anti-dengue IgM antibodies on the 10th day of illness. A non-contrast Computed Tomogram (CT) of the brain showed right frontal lobe hematoma. Thyroid profile showed increased free T3 and T4 and low TSH. Technetium thyroid scan showed reduced tracer uptake. He was diagnosed as having subacute thyroiditis and treated with oral prednisolone and propranolol. Follow up CT brain showed resolving hematoma. Patient’s recovery was uneventful.

Conclusion

Subacute thyroiditis may develop during the course of dengue fever and should be included as a manifestation of expanded dengue syndrome. It should be suspected in patients with dengue fever who develop painful thyroid swelling and clinical features of hyperthyroidism.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO. Dengue hemorrhagic fever: diagnosis, treatment, prevention, and control. 1997, World Health Organization, Geneva, 2 WHO. Dengue hemorrhagic fever: diagnosis, treatment, prevention, and control. 1997, World Health Organization, Geneva, 2
2.
go back to reference WHO: Dengue: Guidelines for diagnosis, treatment, prevention and control. 2009, World Health Organization, Geneva, New edition WHO: Dengue: Guidelines for diagnosis, treatment, prevention and control. 2009, World Health Organization, Geneva, New edition
4.
go back to reference Solomon T, Dung NM, Vaughn DW, et al: Neurological manifestations of dengue infection. Lancet. 2000, 355 (9209): 1053-1059. 10.1016/S0140-6736(00)02036-5.CrossRefPubMed Solomon T, Dung NM, Vaughn DW, et al: Neurological manifestations of dengue infection. Lancet. 2000, 355 (9209): 1053-1059. 10.1016/S0140-6736(00)02036-5.CrossRefPubMed
5.
go back to reference Wani AM, Mejally MA, Hussain WM, et al: Skin rash, headache and abnormal behaviour: unusual presentation of intracranial haemorrhage in dengue fever. BMJ Case Rep. 2010, 2010: Epub 2010 Jan 13 Wani AM, Mejally MA, Hussain WM, et al: Skin rash, headache and abnormal behaviour: unusual presentation of intracranial haemorrhage in dengue fever. BMJ Case Rep. 2010, 2010: Epub 2010 Jan 13
6.
go back to reference Kumar V, Kataria R, Mehta VS: Dengue hemorrhagic fever: a rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian J Ophthalmol. 2011, 59 (4): 311-312. 10.4103/0301-4738.82002.CrossRefPubMedPubMedCentral Kumar V, Kataria R, Mehta VS: Dengue hemorrhagic fever: a rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian J Ophthalmol. 2011, 59 (4): 311-312. 10.4103/0301-4738.82002.CrossRefPubMedPubMedCentral
7.
go back to reference Wildemberg LE, Neto LV, Niemeyer P, et al: Dengue hemorrhagic fever: a condition associated with multiple risk factors for pituitary apoplexy. Endocr Pract. 2012, 31: 1-17. Wildemberg LE, Neto LV, Niemeyer P, et al: Dengue hemorrhagic fever: a condition associated with multiple risk factors for pituitary apoplexy. Endocr Pract. 2012, 31: 1-17.
8.
go back to reference Lazarus JH: Silent thyroiditis and subacute thyroiditis. The Thyroid: A Fundamental and Clinical Text. Edited by: Braverman LE, Utiger RD. 1996, Lippincott Williams & Wilkins, Philadelphia, 577-7 Lazarus JH: Silent thyroiditis and subacute thyroiditis. The Thyroid: A Fundamental and Clinical Text. Edited by: Braverman LE, Utiger RD. 1996, Lippincott Williams & Wilkins, Philadelphia, 577-7
9.
go back to reference Nishihara E, Ohye H, Amino N, et al: Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008, 47: 725-10.2169/internalmedicine.47.0740.CrossRefPubMed Nishihara E, Ohye H, Amino N, et al: Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008, 47: 725-10.2169/internalmedicine.47.0740.CrossRefPubMed
10.
go back to reference Yamamoto M, Saito S, Sakurada T, et al: Effect of prednisolone and salicylate on serum thyroglobulin level in patients with subacute thyroiditis. Clin Endocrinol (Oxf). 1987, 27: 339-10.1111/j.1365-2265.1987.tb01160.x.CrossRef Yamamoto M, Saito S, Sakurada T, et al: Effect of prednisolone and salicylate on serum thyroglobulin level in patients with subacute thyroiditis. Clin Endocrinol (Oxf). 1987, 27: 339-10.1111/j.1365-2265.1987.tb01160.x.CrossRef
Metadata
Title
Expanded dengue syndrome: subacute thyroiditis and intracerebral hemorrhage
Authors
Muhammad Zaman Khan Assir
Ali Jawa
Hafiz Ijaz Ahmed
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-240

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.